Key Points
- Director D. Christian Koch purchased 11,000 Xylem shares for approximately $985,600 at an average price of $89.60, increasing his holdings by 882% to 12,247 shares.
- Xylem’s latest quarterly results slightly missed expectations, with EPS of $1.44 versus $1.45 expected and revenue of $2.20 billion versus $2.28 billion projected; revenue declined 3% year over year.
- The company pays a quarterly dividend of $0.43, equivalent to a 1.9% yield, while analysts maintain a consensus “Hold” rating and an average price target of $121.31.
Xylem Inc. (NYSE:XYL - Get Free Report) Director D Koch purchased 11,000 shares of Xylem stock in a transaction dated Thursday, October 29th. The shares were purchased at an average cost of $89.60 per share, with a total value of $985,600.00. Following the acquisition, the director owned 12,247 shares of the company's stock, valued at approximately $1,097,331.20. This trade represents a 882.12% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Xylem Stock Up 2.8%
Xylem stock opened at $90.74 on Friday. The company has a 50-day simple moving average of $105.47 and a 200-day simple moving average of $117.80. The firm has a market capitalization of $20.81 billion, a P/E ratio of 20.08, a P/E/G ratio of 1.47 and a beta of 1.00. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.39. Xylem Inc. has a one year low of $87.40 and a one year high of $154.27.
Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing analysts' consensus estimates of $1.45 by ($0.01). The firm had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.28 billion. Xylem had a return on equity of 12.06% and a net margin of 11.94%. The firm's revenue was down 3.0% on a year-over-year basis. During the same period last year, the business earned $1.37 EPS. As a group, equities analysts expect that Xylem Inc. will post 5.47 earnings per share for the current year.
Xylem Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th were given a $0.43 dividend. The ex-dividend date was Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.9%. Xylem's dividend payout ratio is 40.95%.
Institutional Investors Weigh In On Xylem
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. bought a new position in Xylem in the 2nd quarter valued at about $2,959,730,000. State Street Corp increased its stake in Xylem by 2.4% during the 2nd quarter. State Street Corp now owns 11,444,669 shares of the industrial products company's stock valued at $1,352,874,000 after buying an additional 270,972 shares during the period. XXEC Inc. bought a new stake in shares of Xylem during the 2nd quarter worth about $850,841,000. Swedbank AB raised its position in shares of Xylem by 0.3% during the 1st quarter. Swedbank AB now owns 5,526,725 shares of the industrial products company's stock worth $660,444,000 after buying an additional 18,759 shares in the last quarter. Finally, Royal Bank of Canada raised its position in shares of Xylem by 1.1% during the 1st quarter. Royal Bank of Canada now owns 4,763,241 shares of the industrial products company's stock worth $569,207,000 after buying an additional 53,210 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts have commented on the stock. Jefferies Financial Group raised their price target on shares of Xylem from $145.00 to $150.00 and gave the company a "buy" rating in a research note on Monday, August 24th. BNP Paribas Exane reduced their price objective on Xylem from $145.00 to $135.00 and set an "outperform" rating for the company in a research report on Wednesday. Mizuho set a $99.00 price objective on Xylem in a research report on Wednesday. Citigroup decreased their price objective on Xylem from $148.00 to $130.00 and set a "buy" rating for the company in a report on Wednesday. Finally, The Goldman Sachs Group lowered their target price on Xylem from $160.00 to $138.00 and set a "buy" rating on the stock in a research report on Wednesday. Nine equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $121.31.
View Our Latest Research Report on XYL
More Xylem News
Here are the key news stories impacting Xylem this week:
- Positive Sentiment: Director D. Christian Koch purchased 11,000 shares worth approximately $985,600, substantially increasing his direct ownership. The transaction may signal confidence that the recent decline has created an attractive entry point. SEC insider trading filing
- Positive Sentiment: Options activity was notably bullish on Thursday, with traders buying 20,508 call options—roughly 771% above typical volume—suggesting some investors are positioning for a rebound.
- Positive Sentiment: RBC Capital reaffirmed its buy rating, while its broader analyst coverage set a “moderate buy” rating and a $125 price target. Other firms, including Citigroup, BNP Paribas Exane, Stifel and Oppenheimer, maintained positive ratings despite lowering their targets. RBC rating article
- Neutral Sentiment: Xylem announced divestitures and a new three-segment structure, which could improve strategic focus and portfolio efficiency but may create near-term execution and transition risks. Xylem restructuring article
- Negative Sentiment: Third-quarter revenue was $2.20 billion, below the $2.28 billion consensus estimate, while adjusted EPS of $1.44 narrowly missed expectations. Revenue declined 3% year over year, and Xylem cut its 2026 outlook. Xylem earnings article
- Negative Sentiment: Barclays downgraded Xylem to equal weight from overweight, while JPMorgan moved to underweight and UBS lowered its target to $99 with a neutral rating. Stifel also cut its target to $114. These actions highlight persistent concerns about near-term growth and valuation. Barclays downgrade article
- Negative Sentiment: Unusual put-option activity, with put volume several times above average, and a law firm’s announced investigation into potential securities-law violations add further risk and uncertainty. Xylem investigation notice
Xylem Company Profile
(
Get Free Report)
Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.
The company's products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
